Editas Medicine (EDIT) Earnings Date & Reports

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EDIT is expected to report earnings to rise 3.38% to -26 cents per share on August 05

Editas Medicine EDIT Stock Earnings Reports

Q2'26

Est.

$-0.27

Q1'26

Beat

by $0.01

Q4'25

Beat

by $0.17

Q3'25

Beat

by $0.02

Q2'25

Missed

by $0.23

The last earnings report on May 05 showed earnings per share of -25 cents, beating the estimate of -26 cents. With 341.73K shares outstanding, the current market capitalization sits at 427.39M.

View a ticker or compare two or three

Compare

EDIT

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for EDIT